← Back to Clinical Trials
Recruiting NCT07119489

NCT07119489 A Novel Dialectical Behavior Therapy Brief Group Intervention for Cigarette Smoking by Patients With Cancer: An Open Clinical Trial

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07119489
Status Recruiting
Phase
Sponsor Wake Forest University Health Sciences
Condition Smoking Behavior
Study Type INTERVENTIONAL
Enrollment 16 participants
Start Date 2026-02-11
Primary Completion 2026-11

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Dialectical Behavior Therapy -Skill Training brief intervention

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 16 participants in total. It began in 2026-02-11 with a primary completion date of 2026-11.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of this research study is to learn more about how Dialectical Behavior Therapy - Skills Training can help patients with cancer who smoke cigarettes cut down on or stop their smoking.

Eligibility Criteria

Inclusion Criteria: 1. Smoke ≥1 cigarettes every day in the past 30 days per participant report. 2. Smoked at least 100 cigarettes (5 packs) in lifetime. 3. Confirmation of cancer diagnosis at any time. 4. Patient encounter with an AHWFBCCC provider within the last two years. 5. Age ≥ 18 years at the time of consent. 6. Ability to understand and willingness to sign an IRB-approved informed consent, in English, directly. 7. Able and willing to participate in video conference. Exclusion Criteria: 1. Patients actively receiving external tobacco use counseling or using tobacco cessation medications. 2. Prior experience with more than five sessions of DBT-ST. 3. Medical or psychiatric conditions limiting compliance with study requirements including suspected or reported cognitive impairment. 4. Self-reported use of any psychoactive substance \[except marijuana and nicotine\] within the last 30 days. 5. Have active and severe suicidal ideation at time of eligibility assessment or suicide attempt within the past month.

Contact & Investigator

Central Contact

James Morgan

✉ jwmorgan@wakehealth.edu

📞 336-712-4491

Principal Investigator

Marcia McCall, PhD

PRINCIPAL INVESTIGATOR

Wake Forest University Health Sciences

Frequently Asked Questions

Who can join the NCT07119489 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Smoking Behavior. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07119489 currently recruiting?

Yes, NCT07119489 is actively recruiting participants. Contact the research team at jwmorgan@wakehealth.edu for enrollment information.

Where is the NCT07119489 trial being conducted?

This trial is being conducted at Charlotte, United States, Winston-Salem, United States.

Who is sponsoring the NCT07119489 clinical trial?

NCT07119489 is sponsored by Wake Forest University Health Sciences. The principal investigator is Marcia McCall, PhD at Wake Forest University Health Sciences. The trial plans to enroll 16 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology